The New Jersey Medical Marijuana Program is moving closer to adding new qualifying conditions including Chronic Pain related to Musculoskeletal Disorders, Migraines, Anxiety, Chronic Pain of Visceral Origin and Tourette’s Syndrome. The Medicinal Marijuana Review Panel is holding a public hearing on Monday, Sept. 18, 2017 for all those wishing to make oral comments to the panel. The panel will take comments from 10 -11 a.m. in the Turning Point Conference Room of the War Memorial, 1 Memorial Drive, Trenton, New Jersey. Click for directions
The panel is also accepting written comments until Sept. 25 from those who can’t make the public hearing. With the hope of helping thousands of suffering patients, CSATC has submitted its written comments in support of approving the new conditions. We encourage all patients and physicians to attend and comment in person at the public hearing or submitting comments in written form in advance.